BlackRock Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $933K | Sell |
129,892
-1,051
| -0.8% | -$7.55K | ﹤0.01% | 2723 |
|
|
2016
Q3 | $1.23M | Buy |
130,943
+5,885
| +5% | +$55.1K | ﹤0.01% | 2522 |
|
|
2016
Q2 | $790K | Buy |
125,058
+17,157
| +16% | +$108K | ﹤0.01% | 2783 |
|
|
2016
Q1 | $596K | Buy |
107,901
+1,843
| +2% | +$10.2K | ﹤0.01% | 2814 |
|
|
2015
Q4 | $592K | Buy |
106,058
+1,061
| +1% | +$5.92K | ﹤0.01% | 2927 |
|
|
2015
Q3 | $888K | Sell |
104,997
-1,883
| -2% | -$15.9K | ﹤0.01% | 2675 |
|
|
2015
Q2 | $1.62M | Buy |
106,880
+23,389
| +28% | +$354K | ﹤0.01% | 2403 |
|
|
2015
Q1 | $1.34M | Buy |
83,491
+1,266
| +2% | +$20.3K | ﹤0.01% | 2323 |
|
|
2014
Q4 | $1.47M | Buy |
82,225
+326
| +0.4% | +$5.81K | ﹤0.01% | 2275 |
|
|
2014
Q3 | $822K | Buy |
81,899
+12,117
| +17% | +$122K | ﹤0.01% | 2644 |
|
|
2014
Q2 | $1.09M | Buy |
69,782
+46,979
| +206% | +$733K | ﹤0.01% | 2531 |
|
|
2014
Q1 | $423K | Buy |
22,803
+3,952
| +21% | +$73.3K | ﹤0.01% | 3020 |
|
|
2013
Q4 | $360K | Buy |
18,851
+4,137
| +28% | +$79K | ﹤0.01% | 3085 |
|
|
2013
Q3 | $240K | Buy |
+14,714
| New | +$240K | ﹤0.01% | 3142 |
|